Dr. Dennis’ clinical and research interests include pediatric acute lymphoblastic leukemia, pediatric lymphomas, and the development of targeted therapies for children with relapsed/refractory leukemia. She received her medical degree from Penn State College of Medicine in Hershey, Pennsylvania. She completed her internship and residency at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Bristol-Myers Squibb Children’s Hospital. Dr. Dennis received her fellowship training from Baylor College of Medicine, Texas Children’s Hospital. Dr. Dennis is currently the Nationwide Children’s Hospital site-PI for the Therapeutic Advances in Childhood Leukemia/Lymphoma (TACL) Phase 1 clinical trial consortium.